]]>(MedPage Today) -- Cenobamate, an investigational antiepileptic drug, significantly reduced focal seizure frequency in a dose-dependent fashion when used as adjunctive therapy, a phase II study showed. Patients with uncontrolled focal (partial...


Read full article on MedPage Today Neurology




 
 

Follow Us on Twitter

Follow Us On Twitter - Image